» Articles » PMID: 30881343

Vitamin D Insufficiency in Overweight and Obese Children and Adolescents

Abstract

Excessive body weight and obesity in childhood and adolescence are becoming more and more important unfavorable factors that entail extremely adverse consequences and require close attention of physicians of any specialty. Along with the high prevalence of obesity and metabolic syndrome in pediatric patients, children and adolescents in the majority of countries are diagnosed with vitamin D deficiency. Among the non-calcaemic effects of vitamin D, a significant role is played by its impact on the hormonal regulation of glucose metabolism and the synthesis of adipokines by fat tissue. The review presents literature data indicative of a close pathogenic relationship between vitamin D insufficiency and impaired tissue insulin sensitivity. It demonstrates the role of vitamin D insufficiency in immune reactions resulting in development of subclinical inflammation in fat tissue infiltrated with macrophages and lymphocytes. It also shows the role of adipokines, immune system cells and pro-inflammatory cytokines produced by them in the pathogenesis of obesity, as well as the function of vitamin D as an endocrine and paracrine regulator of the process of inflammation in adipose tissue. The relationships between the principal adipokines (leptin, adiponectin, resistin) are revealed in the presence of normal vitamin D content and in vitamin D deficiency. The carbohydrate and lipid metabolism parameters in overweight children and adolescents with vitamin D insufficiency are analyzed. A high prevalence of vitamin D insufficiency in overweight and obese children and adolescents (increasing along with the severity of obesity) is demonstrated. The review also presents the current recommendations for the correction of vitamin D insufficiency and underlines the need for higher cholecalciferol doses to achieve serum calcifediol targets in overweight and obese children and adolescents.

Citing Articles

The "Burden" of Childhood Obesity on Bone Health: A Look at Prevention and Treatment.

Farella I, Chiarito M, Vitale R, DAmato G, Faienza M Nutrients. 2025; 17(3).

PMID: 39940349 PMC: 11821239. DOI: 10.3390/nu17030491.


Impact of Time-Restricted Eating and High-Intensity Exercise on Nutrient Intake in Women with Overweight/Obesity: Secondary Analysis of a Randomized Controlled Trial.

Haganes K, Devlin B, Orr R, Moholdt T Nutrients. 2025; 17(2.

PMID: 39861348 PMC: 11767901. DOI: 10.3390/nu17020218.


Vitamin D Deficiency: Insights and Perspectives from a Five-Year Retrospective Analysis of Children from Northeastern Romania.

Ghiga G, Tarca E, Tarca V, Spoiala E, Paduraru G, Gimiga N Nutrients. 2024; 16(22).

PMID: 39599595 PMC: 11597251. DOI: 10.3390/nu16223808.


The Effect of a Multidisciplinary Lifestyle Intervention Program on Apelin-12, Vaspin and Resistin Concentrations in Children and Adolescents with Overweight and Obesity.

Karampatsou S, Paltoglou G, Genitsaridi S, Kassari P, Charmandari E Nutrients. 2024; 16(21).

PMID: 39519480 PMC: 11547676. DOI: 10.3390/nu16213646.


Metabolic Syndrome, Inflammation, Oxidative Stress, and Vitamin D Levels in Children and Adolescents with Obesity.

Hertis Petek T, Homsak E, Svetej M, Marcun Varda N Int J Mol Sci. 2024; 25(19).

PMID: 39408928 PMC: 11476559. DOI: 10.3390/ijms251910599.


References
1.
Sooy K, Schermerhorn T, Noda M, Surana M, Rhoten W, Meyer M . Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. J Biol Chem. 1999; 274(48):34343-9. DOI: 10.1074/jbc.274.48.34343. View

2.
Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P . Alternative versus classical activation of macrophages. Pathobiology. 2000; 67(5-6):222-6. DOI: 10.1159/000028096. View

3.
Wortsman J, Matsuoka L, Chen T, Lu Z, Holick M . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72(3):690-3. DOI: 10.1093/ajcn/72.3.690. View

4.
Zeitz U, Weber K, Soegiarto D, Wolf E, Balling R, Erben R . Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003; 17(3):509-11. DOI: 10.1096/fj.02-0424fje. View

5.
Maestro B, Davila N, Carmen Carranza M, Calle C . Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003; 84(2-3):223-30. DOI: 10.1016/s0960-0760(03)00032-3. View